Lab Coordinator
Tampa/St. Petersburg, Florida Area
Lab maintenance, group task designations, chemical and biological experiments. Research focus on Multiple Myeloma patient response predictions and optical imaging development.Publications:Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma. Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads M, Jacobson T, Silva M, DIstler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski L, Koomen J, Dalton W, Shain K, Wang M, Sotomayor E, Tao JNature Communications (2017) 8: 14920.An ex vivo platform for the prediction of clinical response in multiple myeloma. Silva A, Silva M, Sudalagunta P, Distler A, Jacobson T, Collins A, Nguyen T, Song J, Chen D, Chen L, Cubitt C, Baz R, Perez L, Rebatchouk D, Dalton W, Greene J, Gatenby R, Gillies R, Sontag E, Meads M, Shain KCancer Research (2017) 77(12): 3336-3351.Abstracts:A Novel Approach to Study Evolution of Drug Resistance and Optimum Therapy in Multiple Myeloma.Silva A, Jacobson T, Meads M, Distler A, Silva M, Cubitt C, Perez L, Baz R, Gatenby R, Shain K15th International Myeloma Workshop. Rome, Italy. September 2015.A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma.Shain K, Silva A, Jacobson T, Meads M, Distler A, Gatenby R, Baz R, Silva M, Rebatchouk D, Cubitt C57th American Society of Hematology (ASH) Annual Meeting and Exposition. Orlando, FL. December 2015.